Arnau Iglesias

Badalona, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Chromatin activity of IκBα mediates the exit from naïve pluripotency.

Chromatin activity of IκBα mediates the exit from naïve pluripotency.

Journal: eLife
Published: October 22, 2025

Diverse transcriptomic and mutational patterns but limited functional pathway alterations in patient-derived Sézary syndrome cells.

Diverse transcriptomic and mutational patterns but limited functional pathway alterations in patient-derived Sézary syndrome cells.

Journal: The Journal of investigative dermatology
Published: August 05, 2025

CRISPR-engineered human GATA2 deficiency model uncovers mitotic dysfunction and premature aging in HSPCs, impairing hematopoietic fitness.

CRISPR-engineered human GATA2 deficiency model uncovers mitotic dysfunction and premature aging in HSPCs, impairing hematopoietic fitness.

Journal: Leukemia
Published: August 05, 2025

An unbiased genomewide screen uncovers 7 genes that drive hematopoietic stem cell fate from mouse embryonic stem cells.

An unbiased genomewide screen uncovers 7 genes that drive hematopoietic stem cell fate from mouse embryonic stem cells.

Journal: Blood
Published: November 19, 2024

Human iPSCs-based modeling unveils SETBP1 as a driver of chromatin rewiring in GATA2 deficiency.

Human iPSCs-based modeling unveils SETBP1 as a driver of chromatin rewiring in GATA2 deficiency.

Journal: Nature communications
Published: August 27, 2024

IκBα controls dormancy in hematopoietic stem cells via retinoic acid during embryonic development.

IκBα controls dormancy in hematopoietic stem cells via retinoic acid during embryonic development.

Journal: Nature communications
Published: December 14, 2022

β-Catenin activity induces an RNA biosynthesis program promoting therapy resistance in T-cell acute lymphoblastic leukemia.

β-Catenin activity induces an RNA biosynthesis program promoting therapy resistance in T-cell acute lymphoblastic leukemia.

Journal: EMBO molecular medicine
Published: July 07, 2022

Sézary syndrome patient-derived models allow drug selection for personalized therapy.

Sézary syndrome patient-derived models allow drug selection for personalized therapy.

Journal: Blood advances
Published: December 17, 2021

Epigenetic Silencing of Tumor Suppressor miR-124 Directly Supports STAT3 Activation in Cutaneous T-Cell Lymphoma.

Epigenetic Silencing of Tumor Suppressor miR-124 Directly Supports STAT3 Activation in Cutaneous T-Cell Lymphoma.

Journal: Cells
Published: November 03, 2020
Showing 1-9 of 9

Last Updated: 09/26/2026